Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
MIT biologists have designed a new peptide that can disrupt a key protein that many types of cancers, including some forms of lymphoma, leukemia, and breast cancer, need to survive
This systematic review was recorded in PROSPERO (CRD42024500551)
Role of behavioral interventions in the management of obesity
It works as an agonist - "a substance that mimics the actions of a neurotransmitter or hormone," per the Health Research Board's National Drugs Library - to the brain's GLP-1 receptors
The levels of CD31 in the wound tissue increased gradually from the PBS, blank, and GHK groups to RGD-GHK groups on the 15th day
Kim KS, Park JS, Hwang E, Park MJ, Shin HY, Lee YH, et al
